EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Delivery of Cisplatin for Efficient Immunotherapy of Gasdermin E‐Positive Hepatocellular Carcinoma via a Pt Concentration‐Dependent Minimalist Pyroptosis Strategy

Yun Huang, Shuangyan He, Jiachi Xu, Ting Zou, Jia Liu, Cong Huang, Yalan Chen, Hongdu Liu, Aihua Lei, Hua Wei, Cui-Yun Yu

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yun Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, Universi…. Hauptthemen laut MEDLINE: Pyroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Cisplatin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Key R&D Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compared to the classical Gasdermin D (GSDMD)‐mediated pyroptosis that has been extensively explored for cancer immunotherapy, the direct induction of Gasdermin E (GSDME) pyroptosis has been rarely reported, likely due to the well‐recognized reduced GSDME levels in solid tumors. This study reports the use of a milestone chemotherapeutic drug, cisplatin (CDDP), for effectively inducing inflammatory pyroptosis that depends on the intracellular platinum (Pt) concentration in GSDME‐positive hepatocellular carcinoma identified by bioinformatic analyses. Biomimetic delivery of CDDP via an internalizing arginine‐glycine‐aspartic acid (iRGD)‐functionalized plasma exosome (iRGD‐Pla‐Exo) guarantees an effective tumor intracellular Pt concentration above the threshold for inducing prompt and potent pyroptosis with significantly compromised systematic side effects. The CDDP‐activated antitumor immunity is disclosed to be via the cGAS‐STING pathway activation, including N‐terminal pore‐forming GSDME fragment (GSDME‐NT) production, subsequent perforation on the mitochondrial membrane, and final mitochondrial DNA (mtDNA) release. This nanoplatform, CDDP/1‐bromoacetyl‐3,3‐dinitroazetidine (RRx‐001) @iRGD‐Pla‐Exo nanoparticles (CRRPE NPs) leads to almost complete tumor eradication in a Hepa1‐6‐luc orthotopic liver cancer model by activating macrophages, and can be combined with the commercially available programmed death ligand 1 (PD‐L1) antibody immunomodulator to maintain T cells’ effector function for a prolonged survival lifetime. Overall, this study provides a conceptual advance in revealing the role of chemotherapy in mediating tumor cell pyroptosis and immune cell activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisCarcinoma, HepatocellularLiver NeoplasmsCisplatinImmunotherapyPlatinumBiomimetic MaterialsPhosphate-Binding ProteinsAnimalsHumansMiceCell Line, TumorBiomimeticsAntineoplastic AgentsExosomesGasdermins

Stichwörter der Autor:innen

GSDMEHCCPt concentrationiRGD‐functionalized plasma exosomeinflammatory pyroptosismitochondrial membrane perforation

Substanzen

CisplatinGSDME protein, humanPlatinumAntineoplastic AgentsPhosphate-Binding ProteinsGasdermins

Autor:innen und Institutionen

  • Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China.
  • Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, 410013, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Key R&D Program of Hunan Province
  • Hunan Science and Technology Innovation Leading Talent Project

Zitieren

APA

Huang, Y., He, S., Xu, J., Zou, T., Liu, J., Huang, C., Chen, Y., Liu, H., Lei, A., Wei, H., & Yu, C. Y. (2025). Biomimetic Delivery of Cisplatin for Efficient Immunotherapy of Gasdermin E‐Positive Hepatocellular Carcinoma via a Pt Concentration‐Dependent Minimalist Pyroptosis Strategy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500766

Vancouver

Huang Y, He S, Xu J, Zou T, Liu J, Huang C, et al. Biomimetic Delivery of Cisplatin for Efficient Immunotherapy of Gasdermin E‐Positive Hepatocellular Carcinoma via a Pt Concentration‐Dependent Minimalist Pyroptosis Strategy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500766

BibTeX
@article{Huang2025,
  author = {Huang, Yun and He, Shuangyan and Xu, Jiachi and Zou, Ting and Liu, Jia and Huang, Cong and Chen, Yalan and Liu, Hongdu and Lei, Aihua and Wei, Hua and Yu, Cui-Yun},
  title = {Biomimetic Delivery of Cisplatin for Efficient Immunotherapy of Gasdermin E‐Positive Hepatocellular Carcinoma via a Pt Concentration‐Dependent Minimalist Pyroptosis Strategy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500766}
}
Kostenlos starten →